610 related articles for article (PubMed ID: 20359289)
1. Nanoparticles for tumor targeted therapies and their pharmacokinetics.
Wang J; Sui M; Fan W
Curr Drug Metab; 2010 Feb; 11(2):129-41. PubMed ID: 20359289
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Actively Targeted Nanoparticles for Drug Delivery to Tumor.
Bi Y; Hao F; Yan G; Teng L; Lee RJ; Xie J
Curr Drug Metab; 2016; 17(8):763-782. PubMed ID: 27335116
[TBL] [Abstract][Full Text] [Related]
4. Nanocarriers for cancer-targeted drug delivery.
Kumari P; Ghosh B; Biswas S
J Drug Target; 2016; 24(3):179-91. PubMed ID: 26061298
[TBL] [Abstract][Full Text] [Related]
5. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
6. Passive and active drug targeting: drug delivery to tumors as an example.
Torchilin VP
Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
[TBL] [Abstract][Full Text] [Related]
7. Ligand-directed active tumor-targeting polymeric nanoparticles for cancer chemotherapy.
Zhong Y; Meng F; Deng C; Zhong Z
Biomacromolecules; 2014 Jun; 15(6):1955-69. PubMed ID: 24798476
[TBL] [Abstract][Full Text] [Related]
8. Lipid-based drug delivery systems for cancer treatment.
Arias JL; Clares B; Morales ME; Gallardo V; Ruiz MA
Curr Drug Targets; 2011 Jul; 12(8):1151-65. PubMed ID: 21443475
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in polymeric micelles for anti-cancer drug delivery.
Biswas S; Kumari P; Lakhani PM; Ghosh B
Eur J Pharm Sci; 2016 Feb; 83():184-202. PubMed ID: 26747018
[TBL] [Abstract][Full Text] [Related]
10. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles.
Ernsting MJ; Murakami M; Roy A; Li SD
J Control Release; 2013 Dec; 172(3):782-94. PubMed ID: 24075927
[TBL] [Abstract][Full Text] [Related]
11. Advances in polymeric micelles for drug delivery and tumor targeting.
Kedar U; Phutane P; Shidhaye S; Kadam V
Nanomedicine; 2010 Dec; 6(6):714-29. PubMed ID: 20542144
[TBL] [Abstract][Full Text] [Related]
12. In vivo targeted delivery of nanoparticles for theranosis.
Koo H; Huh MS; Sun IC; Yuk SH; Choi K; Kim K; Kwon IC
Acc Chem Res; 2011 Oct; 44(10):1018-28. PubMed ID: 21851104
[TBL] [Abstract][Full Text] [Related]
13. [The development of novel tumor targeting delivery strategy].
Gao HL; Jiang XG
Yao Xue Xue Bao; 2016 Feb; 51(2):272-80. PubMed ID: 29856581
[TBL] [Abstract][Full Text] [Related]
14. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
15. Active targeting strategies for anticancer drug nanocarriers.
Basile L; Pignatello R; Passirani C
Curr Drug Deliv; 2012 May; 9(3):255-68. PubMed ID: 22452402
[TBL] [Abstract][Full Text] [Related]
16. Threatening cancer with nanoparticle aided combination oncotherapy.
Rawal S; Patel MM
J Control Release; 2019 May; 301():76-109. PubMed ID: 30890445
[TBL] [Abstract][Full Text] [Related]
17. Passive and Active Drug Targeting: Role of Nanocarriers in Rational Design of Anticancer Formulations.
Das RP; Gandhi VV; Singh BG; Kunwar A
Curr Pharm Des; 2019; 25(28):3034-3056. PubMed ID: 31470779
[TBL] [Abstract][Full Text] [Related]
18. Tumor Targeting of Polymeric Nanoparticles Conjugated with Peptides, Saccharides, and Small Molecules for Anticancer Drugs.
Bayram B; Ozgur A; Tutar L; Tutar Y
Curr Pharm Des; 2017; 23(35):5349-5357. PubMed ID: 28911307
[TBL] [Abstract][Full Text] [Related]
19. Current Approaches for Improving Intratumoral Accumulation and Distribution of Nanomedicines.
Durymanov MO; Rosenkranz AA; Sobolev AS
Theranostics; 2015; 5(9):1007-20. PubMed ID: 26155316
[TBL] [Abstract][Full Text] [Related]
20. Gold Nanoparticles in Cancer Therapy: Efficacy, Biodistribution, and Toxicity.
Zhao J; Lee P; Wallace MJ; Melancon MP
Curr Pharm Des; 2015; 21(29):4240-51. PubMed ID: 26323426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
